Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 1038-1042, May 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taukagoshi, S.
Right arrow Articles by Hashimoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taukagoshi, S.
Right arrow Articles by Hashimoto, Y.

Increased Immunosensitivity in Nitrogen Mustard-resistant Yoshida Sarcoma1

Shigeru Taukagoshi and Yoshiyuki Hashimoto

Division of Cancer Chemotherapy, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170, and Tokyo Biochemical Research Institute, 3-41-8 Takada-Minami-cho, Toshima-ku, Tokyo 170, Japan

Yoshida sarcoma cells acquired resistance to nitrogen mustard on repeated in vitro contact with the agent. When rats were inoculated s.c. with these highly resistant Yoshida sarcoma cells (resistance index, 2500) and not treated, initial tumor growth was followed by regression and all of the animals survived. Inoculation was made into the right hind footpad, a site favorable for the experimental induction of lymph node and organ metastases. Among these animals, the size of the right foot enlarged, accompanying lymph node metastasis, but the tumors began to regress starting about 2 weeks after inoculation and disappeared completely after 1 month. With antiserum or peritoneal lymphoid cells obtained from rats immunized with either drug-sensitive or -resistant Yoshida sarcoma cells, it was found that the immunosensitivity of drug-resistant Yoshida sarcoma cells increased in comparison with the cells of the original sensitive line. It is suggested that increased immunosensitivity could account for the observation of greater chemotherapeutic response to 6-mercaptopurine for rats inoculated i.p. with resistant Yoshida sarcoma cells as compared with those inoculated with the original sensitive line.

1 This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Japan.

Received 9/ 8/72. Accepted 1/29/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.